Greystone Housing Impact Investors Files Form 10-K and Issues Investor Schedule K-1s
OMAHA, Neb., March 04, 2024 (GLOBE NEWSWIRE) — Greystone Housing Impact Investors LP, a Delaware limited partnership, (NYSE: GHI) (the […]
Molecular Templates, Inc. Provides Interim Update
AUSTIN, Texas, March 04, 2024 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]
Cerence Names Daniel Tempesta as Chief Financial Officer
BURLINGTON, Mass., March 04, 2024 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that […]
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
The Phase 1b trial of VLS-01 investigates the pharmacokinetics, pharmacodynamics, safety and tolerability of atai’s proprietary, optimized oral transmucosal formulation […]
Global Ship Lease Reports Results for the Fourth Quarter of 2023
LONDON, March 04, 2024 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company”, “Global Ship Lease” or “GSL”), […]
Arcutis Announces Acceptance of Late Breaking Abstract in Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented at the American Academy of Dermatology Annual Meeting
Late breaking sessions to highlight new data from the INTEGUMENT-PED trial evaluating roflumilast cream 0.05% in children ages 2-5 with […]
NV5 Awarded $18 Million by the California Department of Transportation for Construction Management Services
HOLLYWOOD, Fla., March 04, 2024 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of […]
Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors
WATERTOWN, Mass., March 04, 2024 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage […]
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field […]
Infinera’s Award-winning Optical Networking Solutions Recognized and Honored by 2024 Lightwave Innovation Reviews
SAN JOSE, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Infinera (Nasdaq: INFN) announced today its industry-leading optical networking solutions have […]
